{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:45:45Z","timestamp":1740174345537,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T00:00:00Z","timestamp":1581292800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T00:00:00Z","timestamp":1581292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs - Real World Outcomes"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s40801-020-00180-0","type":"journal-article","created":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T16:02:41Z","timestamp":1581350561000},"page":"109-117","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Adverse Drug Reactions in Selected Wards of the Yangon General Hospital and Yangon Specialty Hospital During the First Quarter of 2019: An Active Pharmacovigilance Study in Myanmar"],"prefix":"10.1007","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3913-5757","authenticated-orcid":false,"given":"Lwin Moe","family":"May","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2740-2013","authenticated-orcid":false,"given":"Albert","family":"Figueras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0852-5218","authenticated-orcid":false,"given":"Ye Htut","family":"Linn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maw Than","family":"Htike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi Kun Kaw","family":"San","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nyein Chan","family":"Pyae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khin Hnin","family":"Aye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ei Ei","family":"Aung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilar","family":"Win","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wine","family":"Thawda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zin Wah","family":"Linn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin Min","family":"Kyaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaw Win","family":"Than","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moe Pan","family":"Khaing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thurein","family":"Win","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pyi Phyo","family":"Htet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nu Nu","family":"Aye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,10]]},"reference":[{"key":"180_CR1","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","volume":"279","author":"J Lazarou","year":"1998","unstructured":"Lazarou J, Pomeranz B, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279:1200\u20135.","journal-title":"JAMA"},{"key":"180_CR2","unstructured":"European Commission. Commission staff working document. Pharmacovigilance related activities of Member States and the European Medicines Agency concerning medicinal products for human use (2012\u20132014). https:\/\/ec.europa.eu\/health\/\/sites\/health\/files\/files\/pharmacovigilance\/pharmacovigilance-report-2012-2014_annex_en.pdf. Accessed 23 Oct 2019."},{"key":"180_CR3","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1056\/NEJMsa1103053","volume":"365","author":"DS Budnitz","year":"2011","unstructured":"Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med. 2011;365:2002\u201312. https:\/\/doi.org\/10.1056\/NEJMsa1103053.","journal-title":"N Engl J Med."},{"key":"180_CR4","unstructured":"WHO. The Importance of Pharmacovigilance. http:\/\/apps.who.int\/medicinedocs\/pdf\/s4893e\/s4893e.pdf?ua=1. Accessed 23 Oct 2019."},{"key":"180_CR5","unstructured":"Uppsala Monitoring Center. Members of WHO Programme for International Drug Monitoring. Uppsala Reports 2019;80:4\u20135. https:\/\/view.publitas.com\/uppsala-monitoring-centre\/uppsala-reports-80\/page\/1. Accessed 23 Oct 2019."},{"key":"180_CR6","unstructured":"Aye-Pwint-Phyu, Waing-Thawdar, Ye-Htut-Linn Kay-Khine-Thu, Thida-Tun, Lwin-Moe-May. Myat Myat Soe and Nu-Nu-Aye (2018). Barriers to Implementing Adverse Drug Reaction Reporting System. Technical Report of Department of Pharmacology, University of Medicine 1, Yangon (Thesis), 2018."},{"key":"180_CR7","unstructured":"Thura-Kyaw. Knowledge, attitude and practice of adverse drug reaction reporting system among the assistant surgeons in teaching hospitals. M.Med.Sc (Pharmacology), University of Medicine 2, Yangon (Thesis), 2017."},{"key":"180_CR8","unstructured":"Nang-Khan-Li. Active monitoring of adverse drug reactions on fixed dose combinations of anti-tuberculous drugs. M.Med.Sc (Pharmacology), University of Medicine 2, Yangon (Thesis), 2017."},{"key":"180_CR9","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239\u201345.","journal-title":"Clin Pharmacol Ther."},{"key":"180_CR10","first-page":"2229","volume":"49","author":"SC Hartwig","year":"1992","unstructured":"Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992;49:2229\u201332.","journal-title":"Am J Hosp Pharm"},{"key":"180_CR11","first-page":"1293","volume":"1","author":"AL Raut","year":"2012","unstructured":"Raut AL, Patei P, Patel C, Pawar A. Preventability, predictability and seriousness of adverse drug reactions amongst medicine inpatients in a teaching hospital: a prospective observational study. Int J Pharm Chem Sci. 2012;1:1293\u20139.","journal-title":"Int J Pharm Chem Sci"},{"key":"180_CR12","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s00228-017-2330-3","volume":"73","author":"O Laatikainen","year":"2017","unstructured":"Laatikainen O, Miettunen J, Lehtiniemi H, Tenhunen O. The prevalence of medication-related adverse events in inpatients\u2014a systemic review and meta-analysis. Eur J Clin Parmacol. 2017;73:1539\u201349.","journal-title":"Eur J Clin Parmacol."},{"key":"180_CR13","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1111\/bcp.13081","volume":"82","author":"SL Chan","year":"2016","unstructured":"Chan SL, Ang X, Levana L, Sani LL, Ng HY, Winther MD, Liu JJ, Brunham LLR, Chan A. Prevalence and characteristics of adverse drug reactions at admission to hospital: a prospective observational study. Br J Clin Pharmacol. 2016;82:1636\u201346.","journal-title":"Br J Clin Pharmacol."},{"key":"180_CR14","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/jgs.15800","volume":"67","author":"LM McCarthy","year":"2019","unstructured":"McCarthy LM, Visentin JD, Rochon PA. Assessing the scope and appropriateness of prescribing cascades. J Am Geriatr Soc. 2019;67:1023\u20136. https:\/\/doi.org\/10.1111\/jgs.15800.","journal-title":"J Am Geriatr Soc"},{"key":"180_CR15","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1002\/pds.2193","volume":"20","author":"M P\u00e9rez","year":"2011","unstructured":"P\u00e9rez M, Figueras A. The lack of knowledge about the voluntary reporting system of adverse drug reactions as a major cause of underreporting: direct survey among health professionals. Pharmacoepidemol Drug Saf. 2011;20:1295\u2013302.","journal-title":"Pharmacoepidemol Drug Saf"}],"container-title":["Drugs - Real World Outcomes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-020-00180-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40801-020-00180-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-020-00180-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:25:48Z","timestamp":1612916748000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40801-020-00180-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,10]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["180"],"URL":"https:\/\/doi.org\/10.1007\/s40801-020-00180-0","relation":{},"ISSN":["2199-1154","2198-9788"],"issn-type":[{"type":"print","value":"2199-1154"},{"type":"electronic","value":"2198-9788"}],"subject":[],"published":{"date-parts":[[2020,2,10]]},"assertion":[{"value":"10 February 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Lwin Moe May, Albert Figueras, Ye Htut Linn, Maw Than Htike, Mi Kun Kaw San, Nyein Chan Pyae, Khin Hnin Aye, Ei Ei Aung, Nilar Win, Wine Thawda, Zin Wah Linn, Yin Min Kyaw, Ya Min, Zaw Win Than, Moe Pan Khaing, Thurein Win, Pyi Phyo Htet, Nu Nu Aye have no conflicts of interest that are directly relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This research was funded by the Department of Medical Research External Grant 2019 (ID: 12\/2019) of the Ministry of Health and Sports, Republic of the Union of Myanmar. Training and consultancy activities by Albert Figueras were partly supported by the Asian Development Bank (TA-8763 REG: Drug Safety Expert)\u2014(replacement of regulatory specialist\/contract no. 120958-S85781).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The Ethics Review Committee, Department of Medical Research, Ministry of Health and Sports, Republic of the Union of Myanmar, approved this study (approval number: Ethics\/DMR\/2018\/131). All procedures performed in this study were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Written informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}